These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7187965)

  • 1. [Methods of studying the sensitivity of Chlamydia trachomatis to antibiotics].
    Laurans G; Orfila J; Haider F
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (2-3):93-106. PubMed ID: 7187965
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro sensitivity of Chlamydiae to antibiotics].
    Dailloux M; Ottemer C; Albert H; Weber M
    Pathol Biol (Paris); 1990 May; 38(5):426-30. PubMed ID: 2195451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro, activity of a new macrolide (RU 28965) against Chlamydia trachomatis and Ureaplasma urealyticum].
    Sambri V; Rumpianesi F; Franchi L; Cevenini R
    G Ital Chemioter; 1985; 32(1):175-6. PubMed ID: 3830774
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of various antibiotics on the TRIC agent (M R C4 strain) cultivated on chick embryos].
    Belabbas N; Aouchiche M
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1981; (3-4):87-96. PubMed ID: 7187533
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of ++clarithromycin against mycoplasma and chlamydia].
    Franzoso G; Cusinato R; Tonin EA; Meloni GA
    G Ital Chemioter; 1991; 38(1-3):159-61. PubMed ID: 1365578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sensitivity of strains of Chlamydia trachomatis to various chemo-antibiotics. Additional observations].
    Milici M; Indellicati G; Giambanco R; Licata R; Chiarini A
    G Ital Chemioter; 1984; 31(1-2):37-40. PubMed ID: 6468831
    [No Abstract]   [Full Text] [Related]  

  • 7. Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities.
    Storey C; Chopra I
    Antimicrob Agents Chemother; 2001 Jan; 45(1):303-5. PubMed ID: 11120983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effector of antibiotics on the Chlamydia family.
    Orfila J; Laurans G
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (1):7-82. PubMed ID: 7178707
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential of a novel polyherbal formulation BASANT for prevention of Chlamydia trachomatis infection.
    Bhengraj AR; Dar SA; Talwar GP; Mittal A
    Int J Antimicrob Agents; 2008 Jul; 32(1):84-8. PubMed ID: 18524545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time PCR for pharmacodynamic studies of Chlamydia trachomatis.
    Storm M; Gustafsson I; Herrmann B; Engstrand L
    J Microbiol Methods; 2005 Jun; 61(3):361-7. PubMed ID: 15767012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
    Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
    J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
    Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
    Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on activities of eight kinds of traditional Chinese medicine against urogential Chlamydia trachomatis].
    Li J; Tu Y; Tong J; Wang P
    Zhong Yao Cai; 1999 Aug; 22(8):414-5. PubMed ID: 12571890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of a new quinoline derivative against Chlamydia trachomatis].
    Mitsui Y; Higashitsutsumi M
    Nippon Ganka Gakkai Zasshi; 1986 Aug; 90(8):1074-80. PubMed ID: 3464167
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the in vitro activity of various antibiotics against Chlamydia trachomatis by indirect immunoperoxidase method].
    Bannai H; Miyazawa H; Ashihara Y
    Kansenshogaku Zasshi; 1986 Oct; 60(10):1140-6. PubMed ID: 3100692
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activities of thirteen beta-lactam antibiotics against Chlamydia trachomatis.
    Muytjens HL; Heessen FW
    Antimicrob Agents Chemother; 1982 Sep; 22(3):520-1. PubMed ID: 7137988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of antimicrobials against Chlamydia trachomatis in vitro.
    Ridgway GL; Oriel JD
    J Antimicrob Chemother; 1979 Jul; 5(4):483-4. PubMed ID: 489497
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of ofloxacin against Chlamydia trachomatis.
    Møller BR; Evans R; Kaspersen P; From E
    Drugs; 1987; 34 Suppl 1():181-3. PubMed ID: 3481321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.